Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIORITY trial in type 2 diabetes with normoalbuminuria
2012-000452-34Phase 2Completed
- Sponsor
- Steno Diabetes Center
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of spironolactone in diabetic glomerulosclerosis (3 arms), sponsored by Steno Diabetes Center. Started Sep 2013; status: completed.
02
Drugs
spironolactone
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on 2012-000452-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000452-34.